- CLEW closes a $20M Series B round of funding to scale US operations and commercialize CLEW’s critical care platform. - CLEW is a real-time AI analytics platform designed to help providers make better informed clinical decisions by predicting life-threatening complications across various medical care settings.CLEW, a digital health startup announced that it has successfully concluded its Series B funding, bringing the total capital raised to over $20 million. The round was led by Pitango
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Concerto HealthAI Raises $150M to Expand RWD Solutions for Precision Oncology
- Concerto HealthAI, a provider of real-world evidence (RWE) services for precision oncology raises $150M in Series B funding led by Declaration Partners. - Series B funding will power next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes. Concerto HealthAI, a Boston, MA-based provider of Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology raised $150 million in aggregate Series B financing. The round of financing was
Read More
DrChrono Raises $20M to Expand EHR Platform into Larger Facilities & Specialty Practices
- DrChrono raises $20M in growth capital from ORIX Capital to expand into large practice markets and investing in the platform: EHR, Billing, RCM, Machine Learning, API software, and services. - To date, the DrChrono platform is used by thousands of physicians and has over 17.8 million patients under the care of DrChrono providers. DrChrono Inc., the company developing the essential platform and services for modern medical practices to make care more informed, more interactive, and more
Read More
Virta Health Raises $93M to Expand Clinically Proven Treatment to Reverse Type 2 Diabetes
- Virta Health raises $93M in Series C funding round to expand its clinically proven treatment to reverse type 2 diabetes. - Funding will enable investing in growth and research to meet the demand for T2D reversal from employers, health plans and government. Virta Health, a San Francisco, CA-based company delivering the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) has raised $93M in Series C funding led by Caffeinated Capital. The round also included
Read More
Kyruus Lands $42M to Expand Patient-Providing Matching Solutions for Health Systems
- Kyruus, a provider search and scheduling solutions company raises $42 million in a Series D round led by Venrock and Highland Capital Partners, with financing from other VCs such as Providence Ventures and Salesforce Ventures. - Kyruus will tap into the new funds to enhance its product suite for health systems and forge partnerships with payers and large employers, as consumers also seek providers via those entities.Kyruus, a Boston, MA-based suite of patient-provider matching solutions for
Read More
Ride Health Lands $6.2M to Deliver Real-Time Ride Coordination Platform
- Ride Health, an NYC-based real-time ride coordination platform that improves access to care and patient’s ride experience has raised $6.2M in seed funding. - Penn Medicine is already using Ride Health’s ride coordination platform to reduce costs, no-shows, and length-of-stay. - Ride Health now supports transportation benefit management for health plans in 10 states, optimizing utilization across all transportation modes including mileage reimbursement, public transit, ride-hailing,
Read More
ObjectiveGI Raises $6.6M for Integrated GI Research to Address NASH Epidemic
- ObjectiveGI, the Nashville-based clinically integrated ancillary care platform has raised $6.6M in Series A funding.
- Taking on the rising NonAlcoholic SteatoHepatitis (NASH) epidemic, ObjectiveGI establishes premier clinical trial centers within local gastroenterology (GI) practices across the country to develop new therapies and improve patient outcomes.
- The company opened its 10th Center of Research Excellence in September 2019 and, with this funding, ObjectiveGI aims to double
Read More
DarioHealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes & Hypertension
- DarioHealth closed on a private placement of $21.3M in convertible preferred stock to institutional and private investors.- Proceeds of the financing will be deployed to accelerate B2B partnerships with payer organizations who can commit subscribers in the thousands, to reinforce D2C, and to expand their product lineup beyond their current diabetes and hypertension offering.Global digital therapeutics innovation provider, DarioHealth Corp. (NASDAQ: DRIO), announced that it has closed on a
Read More
Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem to Accelerate Biomarker Discovery
- Paige raises $45M in Series B funding led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others. - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada. Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More
Bright Health Lands $635M to Expand Medicare Advantage Plans to More Markets
- Bright Health, a diversified consumer-focused healthcare company announced it has raised $635M in Series D funding led by NEA. - The funding will be used to support Bright Health's aggressive growth and hiring as the company continues to strategically expand across products, geographies and consumer bases.- With this round, Bright Health has raised over a billion dollars in equity financing since early 2016, reaching "unicorn status" with a valuation of over $1B. Bright Health, a diversified
Read More
